
Regulated Amino H2O
$10.00
Important research use notice For qualified laboratory research only. Not for human or animal use.
Read notice ↗
Product artwork. Refer to the supplied label and batch documentation.
CJC-1295 / Ipamorelin is a catalog-listed peptide blend. The CJC-1295 variant and DAC status require supplier confirmation.
Per product and strength, off the regular price. Automatic savings; discounts cannot be combined.
Complimentary 2-day delivery on bulk orders.
Order multiple products in bulk ↗CONTINUE YOUR RESEARCH
Explore related research materials and lab essentials. Choose a size and add it straight to your bag.
Shop all products ↗
↗Lab essentials
GH signalingMetabolic research↗Peptide blends
GH signaling↗Research peptides
GH signaling↗Nasal formats
Tissue & matrix↗Peptide blends
Dermal biologyTissue & matrix↗Peptide blends
DOCUMENTATION, MADE ACCESSIBLE
Review the evidence for CJC-1295 / Ipamorelin — 5/5 MG. Published results must be traceable to the original report and the lot on your packaging.
LATEST PUBLISHED RECORD
Freedom Diagnostics · Reported August 11, 2026
The certificate does not specify CJC-1295 DAC status. Purity is reported for the blend, not separately for each ingredient.
Method: LC-MS
Method: HPLC-UV
Report method: HPLC with UV detection coupled with mass spectrometry (LC-MS).
Results are transcribed from the linked certificate after store review. Check the original report and match the lot before relying on a result. “Not reported” does not mean an analysis passed.
A TRACEABLE RESEARCH RECORD
The archive for CJC-1295 / Ipamorelin — 5/5 MG. Only published, reviewed records are listed; an absent lot has no published documentation here.
The certificate does not specify CJC-1295 DAC status. Purity is reported for the blend, not separately for each ingredient.
TECHNICAL SPECS
Catalog details and published reference information for CJC-1295 / Ipamorelin. Reference compound properties are separate from the identity, composition, and results of an individual batch.
Follow the supplied label and supplier documentation for handling and storage. A batch-specific storage temperature, shelf life, salt form, and complete formulation have not been verified here.
GHRH analogue; catalog variant unresolved
CJC-1295 is a growth-hormone-releasing-hormone analogue studied through receptor assays, animal experiments and controlled human endocrine studies. The cited papers concern an albumin-binding, DAC-containing variant. Because the catalog does not identify DAC status, that variant cannot be assumed to match its CJC-1295 ingredient, and these studies do not evaluate the listed blend.
Reference information does not confirm the salt, variant, composition, or identity supplied in this catalog item.
Synthetic pentapeptide secretagogue
Ipamorelin is a synthetic pentapeptide containing nonstandard amino-acid residues and an amidated terminus. It is classified as a growth hormone secretagogue and ghrelin-receptor ligand. Its research literature includes pituitary-cell assays, animal endocrine studies, and human pharmacokinetic modeling that links measured peptide concentrations with growth hormone responses.
Reference information does not confirm the salt, variant, composition, or identity supplied in this catalog item.
PEER-REVIEWED LITERATURE
Published compound and ingredient research is provided as scientific context for CJC-1295 / Ipamorelin. These papers do not verify this supplier’s product, its finished formulation, or any batch. Study findings are specific to the model and conditions described.
Cultured rat pituitary cells and rats were used to characterize albumin-binding GHRH analogues, including the chemically modified CJC-1295 variant.
Ingredient context: CJC-1295Two placebo-controlled studies measured endocrine and pharmacokinetic endpoints for long-acting CJC-1295 in healthy adults; the listed blend and its unspecified CJC variant were not evaluated.
Ingredient context: CJC-1295The original pharmacology study characterized ipamorelin in primary rat pituitary cells and in rat and swine endocrine experiments.
Ingredient context: IpamorelinA volunteer study modeled the relationship between circulating ipamorelin concentrations and measured growth hormone responses.
Ingredient context: IpamorelinIMPORTANT RESEARCH USAGE NOTICE
CJC-1295 / Ipamorelin is offered exclusively for controlled laboratory research by qualified professionals. Not for human or animal use, consumption, or administration.
Products are not intended to diagnose, treat, cure, or prevent disease. Literature is provided for research reference and is not medical advice or evidence validating this product. Purchasers must meet the store’s research eligibility requirements and review the supplied documentation before use.
Read the research use policy ↗DOCUMENTATION, MADE ACCESSIBLE
Review the evidence for CJC-1295 / Ipamorelin — select mass. Published results must be traceable to the original report and the lot on your packaging.
CJC-1295 / Ipamorelin — select mass documentation will appear here after the actual report is uploaded and reviewed. No purity, identity, or pass/fail result is implied.
Request a batch COA →Awaiting the original batch certificate.
Awaiting the original batch certificate.
Awaiting the original batch certificate.
Awaiting the original batch certificate.
A TRACEABLE RESEARCH RECORD
The archive for CJC-1295 / Ipamorelin — select mass. Only published, reviewed records are listed; an absent lot has no published documentation here.
No batch records have been published for this product yet.
Ask about your batch ↗